Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Platinum Compounds × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 15 Gastrointestinal 2 Other solid neoplasm 1 Gynecologic 1

Conditions

Retinoblastoma 1

Interventions

Injections 45 pembrolizumab 38 Bevacizumab 21 Carboplatin 20 Cyclophosphamide 16 Cisplatin 14 Paclitaxel 13 tislelizumab 12 fludarabine 12 Specimen Handling 11 Nivolumab 11 Interviews as Topic 11 toripalimab 10 Standard of Care 10 Practice Guidelines as Topic 10 Cetuximab 10 Pemetrexed 9 Oxaliplatin 9 Fluorouracil 9 Docetaxel 9 atezolizumab 8 Leucovorin 7 Capecitabine 7 spartalizumab 6 olaparib 6 Irinotecan 6 Educational Status 6 palbociclib 5 lenvatinib 5 Ipilimumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04681417 2025-11-28

RETINO 2018

Institut Curie

Phase 2/3 Recruiting

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡